Literature DB >> 6146859

Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects.

R Nanda, U Baveja, B S Anand.   

Abstract

To examine whether Entamoeba histolytica is the cause of a variety of intestinal disorders, as often implicated, a two-part study was conducted. In part 1, 184 patients attending a gastroenterology clinic and needing a sigmoidoscopy had a rectal biopsy specimen and a stool sample cultured for E histolytica. Part of the biopsy specimen was examined histologically. In addition, serum was tested for antibody to E histolytica. 34 (18.7%) patients were culture positive. There was no correlation between the culture results and patients' symptoms except for diarrhoea, which was more common in the culture-negative group, or with histological or serological findings. In the second part of the study, 15 culture-positive patients were followed up untreated for a mean (+/- SD) of 8.6 (+/- 4.9) months, range 1-18. In all 15 patients spontaneous eradication of the parasite occurred, and in none did symptoms of invasive amoebiasis develop. Thus E histolytica seems not to be responsible for many of the bowel complaints commonly attributed to it. In these cyst passers the cysts are probably incidental to an irritable bowel syndrome or some other organic disease. There seems to be little justification for treating cyst passers since eradication of the parasite occurs spontaneously and the danger of invasive amoebiasis is negligible. Such a practice would result in an enormous saving on the cost of drugs.

Entities:  

Mesh:

Year:  1984        PMID: 6146859     DOI: 10.1016/s0140-6736(84)92682-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal anti-lectin immunoglobulin A antibody response.

Authors:  Mohamed D Abd-Alla; Terry F G H Jackson; Tyson Rogers; Selvan Reddy; Jonathan I Ravdin
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  Outcome of untreated infection with Entamoeba histolytica in homosexual men with and without HIV antibody.

Authors:  E Allason-Jones; A Mindel; P Sargeaunt; D Katz
Journal:  BMJ       Date:  1988-09-10

Review 4.  Parasitic diarrhoea.

Authors:  R C Mahajan; N K Ganguly; R Sehgal; N Malla
Journal:  Indian J Pediatr       Date:  1988 Nov-Dec       Impact factor: 1.967

5.  Which amoebae are harmful?

Authors:  V K Vinayak
Journal:  Indian J Pediatr       Date:  1985 Sep-Oct       Impact factor: 1.967

6.  Postinfectious Irritable Bowel Syndrome.

Authors:  Kok-Ann Gwee
Journal:  Curr Treat Options Gastroenterol       Date:  2001-08

7.  Entamoeba histolytica cyst passers. Clinical profile and spontaneous eradication of infection.

Authors:  B S Anand; A K Tuteja; M Kaur; S M Alam; D S Aggarwal; S P Mehta; U K Baveja
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

8.  Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.

Authors:  Fariborz Mansour-Ghanaei; Najaf Dehbashi; Kamyar Yazdanparast; Afshin Shafaghi
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 9.  Host-pathogen interaction in amebiasis and progress in vaccine development.

Authors:  C D Huston; W A Petri
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

Review 10.  Amebiasis.

Authors:  D A Bruckner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.